Tracking the PRLD option chain helps you see every strike and expiry on Prelude Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Prelude Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PRLD options activity at a glance. Use our scanner to monitor the PRLD option chain in real time and filter for the PRLD options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PRLD stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PRLD option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PRLD stock options are being actively traded and where they are not.
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors.
The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Prelude Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen PRLD options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PRLD stock options — let the full option chain come to you, pre-filtered and ready to trade.
